1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Pharmaceutical Supply Chain: Navigating Complexity

Admin
1 March 2024

The pharmaceutical supply chain is a complicated network of sources of raw materials, production, distribution and delivery of medicinal products to patients. In order to ensure that patients receive safe and effective medical care, the pharma supply chain network consists of various stakeholders so it needed careful coordination and compliance with regulatory guidelines at all stages. Let us take a look at the fundamentals and key elements in this blog.

Stakeholders in Supply Chain

Collaboration between various stakeholders is crucial for the success of the supply chain in pharmaceutical industry:

Raw Material Suppliers: In the production of drugs, these providers supply basic ingredients.
Drug Manufacturers: They're making the final pharmaceutical products.
Regulatory Agencies: The guidelines are enforced and safety and quality are ensured by these bodies.
Wholesale Distributors: It facilitates the movement of medicinal products between manufacturers and pharmacies.
Pharmacies and its Benefit Managers (PBMs): Patients are given medicinal products by such entities.
Healthcare Providers: In prescribing and administering medicinal products, they play an important role.
Patients: The final beneficiaries who have relied on timely access to medicinal products.

Journey of new drug through the Supply Chain

Let us take a look at the typical path taken by medicinal products:

Manufacturing: The drugs are produced at the production sites.
Wholesale Distribution: They're being transferred to wholesale distributors.
Pharmacy Stocking: Pharmaceuticals find their way to various types of pharmacies, including retail and mail-order.
Pharmacy Benefit Management (PBM): PBMs negotiate prices and guarantee quality checks.

Challenges and Strategies

There are a number of challenges in the supply chain for pharmaceuticals:

Supply Chain Visibility: Ensuring that drug movements are transparent and real-time monitored.
Drug Counterfeiting: Preventing the entry of counterfeit medicines into the supply chain.
Cold-Chain Shipping: During transport, maintain the temperature sensitive drugs.
Rising Drug Prices: Preserving affordability and access for patients.

India’s Role in the Global Pharma Supply Chain

India's pharmaceutical industry, often referred to as the world's "pharmacy," has seen steady and sturdy growth. At present, it covers around 60% of the global vaccine demand and responsible for more than 20% of the world pharma supply chain. Indian pharma industry is growing with current value of USD 40 billion in 2021 and it is anticipated to reach USD 130 billion by 2030 and USD 450 billion by 2047. (Courtesy: Maersk)

Future Trends

The pharmaceutical supply chain will continue to adapt as technological progress and global health needs evolve. Its course will be shaped by innovation in logistics, data analysis and sustainability.

Chemxpert Database and Pharma Supply Chain

The Chemxpert database, pharma database service provider company, has a key role to play in the pharmaceutical supply chain, affecting various sectors of the industry as follows:

Regulatory Compliance:

Comprehensive registration, authorization and regulatory filing data are available in the Chemxpert database.
It covers applications specified by regulatory bodies for active pharmaceutical ingredients (APIs) and product commercialization.
This ensures that drug manufacturers adhere to applicable laws and maintain strict safety and efficacy standards.

Key Pharma Titans:

The database of Chemxpert provides information on the customers, suppliers, market size, study data, regulatory insight and trends in pricing.
It's a one stop shop for the procurement, marketing, business development, research, production and regulatory responsibilities.
Effective communication between enterprises and their suppliers, buyers or others in the industry can be achieved.

Industrial Labs:

Technical information such as synthesis routes, mechanisms of action and details on suppliers of raw materials are available in the Chemxpert database.

Unveiling Industry Updates:

In the pharmaceutical industry, it is important to keep up with recent trends.
Current data and information on market trends are available in the Chemxpert database.
Its DataFeed features, which keep users informed of advances in the field of life sciences and pharmaceuticals, give a thorough selection of news and trends.

Conclusion

In conclusion, the supply chain of pharmaceuticals is a lifeline that connects scientific discovery to good health for patients. We can achieve a common access to existing and new medicines, thereby improving health outcomes worldwide through addressing challenges and promoting collaboration.